Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,121 | 1,119 | N/A |
| Receivables | 1,882 | 1,088 | N/A |
| TOTAL | $3,031 | $2,207 | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 303 | 303 | 0 |
| Other Non-Current Assets | 157 | 0 | 0 |
| TOTAL | $460 | $303 | $N/A |
| Total Assets | $3,491 | $2,510 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 4,095 | 3,804 | 0 |
| Accrued Expenses | 1,115 | 194 | N/A |
| Other current liabilities | 1,576 | 655 | N/A |
| TOTAL | $9,189 | $4,653 | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $9,189 | $4,653 | $N/A |
| Shareholders' Equity | |||
| Common Shares | N/A | 10,885 | N/A |
| Retained earnings | -28,809 | -24,806 | N/A |
| Other shareholders' equity | 12,593 | 0 | 0 |
| TOTAL | $-5,698 | $-2,143 | $N/A |
| Total Liabilities And Equity | $3,491 | $2,510 | $0 |